| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/MCP.M112.021816 |
| P953 | full work available at URL | https://www.mcponline.org/content/mcprot/12/1/207.full.pdf |
| P932 | PMC publication ID | 3536901 |
| P698 | PubMed publication ID | 23111923 |
| P7228 | access restriction status | open access | Q232932 |
| P2093 | author name string | Liang Chen | |
| Ying Wang | |||
| Peng Xie | |||
| Jiaju Zhong | |||
| Huaqing Meng | |||
| Peng Zheng | |||
| Yang Lei | |||
| Deyu Yang | |||
| Dezhi Zhou | |||
| N D Melgiri | |||
| P2860 | cites work | Systems biology: Metabonomics | Q47647280 |
| Brain and mind: a challenge for WHO. | Q48284196 | ||
| Urinary metabonomic study using a CUMS rat model of depression. | Q48722707 | ||
| Plasma metabonomics as a novel diagnostic approach for major depressive disorder. | Q48760949 | ||
| Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression. | Q51878541 | ||
| Understanding the heterogeneity of depression through the triad of symptoms, course and risk factors: a longitudinal, population-based study. | Q52922033 | ||
| A preliminary metabolomic analysis of older adults with and without depression. | Q53586508 | ||
| Major Depressive Disorder | Q56016676 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| The use of the area under the ROC curve in the evaluation of machine learning algorithms | Q56594447 | ||
| OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification | Q58045925 | ||
| Nuclear Magnetic Resonance Spectroscopic and Principal Components Analysis Investigations into Biochemical Effects of Three Model Hepatotoxins | Q58046285 | ||
| 1H-NMR-based metabolomics study of cerebral infarction | Q83809378 | ||
| The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
| 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data | Q29784220 | ||
| Identification of targeted analyte clusters for studies of schizophrenia | Q30476776 | ||
| Analysis of metabolomic data using support vector machines | Q33366103 | ||
| A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics | Q33425717 | ||
| PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review | Q33837972 | ||
| Depression in patients with irritable bowel syndrome in Jos, Nigeria | Q33866737 | ||
| Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis | Q34047987 | ||
| A Structured Interview Guide for the Hamilton Depression Rating Scale | Q34049786 | ||
| Brain oxygenation and energy metabolism: part I-biological function and pathophysiology | Q34786721 | ||
| Bladder cancer determination via two urinary metabolites: a biomarker pattern approach | Q35497484 | ||
| Urinary metabolite markers of precocious puberty | Q35722258 | ||
| Potential metabolite markers of schizophrenia. | Q36479055 | ||
| End-product regulation of the tryptophan-nicotinic acid pathway in Neurospora crassa | Q36773311 | ||
| Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel. | Q36936018 | ||
| Metabolic profiling of human blood serum from treated patients with bipolar disorder employing 1H NMR spectroscopy and chemometrics | Q39934894 | ||
| Study of plasma metabolic profiling and biomarkers of chronic unpredictable mild stress rats based on gas chromatography/mass spectrometry | Q42810492 | ||
| Discrimination of the geographical origin of beef by (1)H NMR-based metabolomics | Q42911041 | ||
| Metabonomics study of urine and plasma in depression and excess fatigue rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry | Q43010213 | ||
| Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls | Q43119044 | ||
| Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. | Q43187905 | ||
| Urinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression | Q43242552 | ||
| Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. | Q43625342 | ||
| Clinical diagnosis of depression in primary care: a meta-analysis | Q44323103 | ||
| Reduction of prefrontal cortex glucose metabolism common to three types of depression | Q45097380 | ||
| Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. | Q45222765 | ||
| Metabonomics approach to understanding acute and chronic stress in rat models. | Q46085536 | ||
| P433 | issue | 1 | |
| P921 | main subject | major depressive disorder | Q42844 |
| Homo sapiens | Q15978631 | ||
| biomarker | Q864574 | ||
| malonic acid | Q421972 | ||
| P6954 | online access status | open access | Q232932 |
| P304 | page(s) | 207-214 | |
| P577 | publication date | 2012-10-30 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Identification and validation of urinary metabolite biomarkers for major depressive disorder | |
| P478 | volume | 12 |
| Q50663896 | 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder. |
| Q93167649 | Age-specific urinary metabolite signatures and functions in patients with major depressive disorder |
| Q35167250 | Berberine ameliorates nonbacterial prostatitis via multi-target metabolic network regulation |
| Q35240539 | Bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials |
| Q38366733 | Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses |
| Q61447375 | Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study |
| Q58573891 | Chronic Stress Disturbs Metabolome of Blood Plasma and Urine in Diabetic Rats |
| Q90216698 | Chronic Stress in a Rat Model of Depression Disturbs the Glutamine-Glutamate-GABA Cycle in the Striatum, Hippocampus, and Cerebellum |
| Q35861541 | Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum. |
| Q37733240 | Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder. |
| Q92373464 | Comprehensive urinary metabolomic characterization of a genetically induced mouse model of prostatic inflammation |
| Q47838435 | D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression |
| Q89507956 | Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study |
| Q35604108 | Differential co-expression and regulation analyses reveal different mechanisms underlying major depressive disorder and subsyndromal symptomatic depression |
| Q55032429 | Differentiating Medicated Patients Suffering from Major Depressive Disorder from Healthy Controls by Spot Urine Measurement of Monoamines and Steroid Hormones. |
| Q38830302 | Discriminating poststroke depression from stroke by nuclear magnetic resonance spectroscopy-based metabonomic analysis |
| Q89747520 | Dl-3-n-butylphthalide attenuates mouse behavioral deficits to chronic social defeat stress by regulating energy metabolism via AKT/CREB signaling pathway |
| Q37398383 | Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies |
| Q97519611 | Extracellular Matrix and Oxidative Phosphorylation: Important Role in the Regulation of Hypothalamic Function by Gut Microbiota |
| Q50635567 | GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells. |
| Q57161916 | GC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old age |
| Q55714791 | Ginkgo biloba extract and its diterpene ginkgolide constituents ameliorate the metabolic disturbances caused by recombinant tissue plasminogen activator in rat prefrontal cortex. |
| Q46565524 | Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism |
| Q58759636 | Gut microbiota regulates mouse behaviors through glucocorticoid receptor pathway genes in the hippocampus |
| Q37648213 | Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics |
| Q47436744 | Imbalance in amino acid and purine metabolisms at the hypothalamus in inflammation-associated depression by GC-MS. |
| Q40058836 | Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry. |
| Q41548141 | Insight into the metabolic mechanism of Diterpene Ginkgolides on antidepressant effects for attenuating behavioural deficits compared with venlafaxine. |
| Q64061225 | Integrated Metabolomics and Proteomics Analysis Revealed Second Messenger System Disturbance in Hippocampus of Chronic Social Defeat Stress Rat |
| Q35188855 | Macaques exhibit a naturally-occurring depression similar to humans |
| Q27342472 | Maternal Weaning Modulates Emotional Behavior and Regulates the Gut-Brain Axis. |
| Q47642189 | Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers |
| Q35200833 | Metabolite profiling in posttraumatic stress disorder |
| Q40613040 | Metabolomics strategy reveals therapeutical assessment of limonin on nonbacterial prostatitis |
| Q94560996 | Metabonomic Profile and Signaling Pathway Prediction of Depression-Associated Suicidal Behavior |
| Q64076445 | Metabonomics reveals peripheral and central short-chain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques |
| Q37116628 | Microbiota Modulates Behavior and Protein Kinase C mediated cAMP response element-binding protein Signaling |
| Q97644938 | NMR-Based Metabonomic Study Reveals Intervention Effects of Polydatin on Potassium Oxonate-Induced Hyperuricemia in Rats |
| Q33704082 | Novel urinary metabolite signature for diagnosing postpartum depression |
| Q64060695 | Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics |
| Q52879696 | Omega-3 Fatty acids as Monotherapy in Treating Depression in Pregnant Women: a Meta- Analysis of Randomized Controlled Trials. |
| Q94560655 | Overview of Brain-to-Gut Axis Exposed to Chronic CNS Bacterial Infection(s) and a Predictive Urinary Metabolic Profile of a Brain Infected by Mycobacterium tuberculosis |
| Q48220933 | Peripheral blood mononuclear cell-based metabolomic profiling of a chronic unpredictable mild stress rat model of depression |
| Q55333947 | Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics. |
| Q46511372 | Plasma lipidomics reveals potential lipid markers of major depressive disorder |
| Q52573336 | Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents. |
| Q88220686 | Prophylactic ketamine alters nucleotide and neurotransmitter metabolism in brain and plasma following stress |
| Q30801268 | Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder |
| Q26786208 | Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression |
| Q27023402 | Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers |
| Q39610291 | Serum proteomic profiles of depressive subtypes |
| Q37347574 | Serum proteomic profiling of major depressive disorder |
| Q35848353 | Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study |
| Q52665670 | Sex differences in gut microbiota in patients with major depressive disorder. |
| Q93052866 | Sex-Specific Associations of Trimethylamine-N-Oxide and Zonulin with Signs of Depression in Carbohydrate Malabsorbers and Nonmalabsorbers |
| Q34757521 | Sex-specific urinary biomarkers for diagnosing bipolar disorder |
| Q57491015 | Short Term Intrarectal Administration of Sodium Propionate Induces Antidepressant-Like Effects in Rats Exposed to Chronic Unpredictable Mild Stress |
| Q41791000 | Short overview on metabolomic approach and redox changes in psychiatric disorders. |
| Q33614561 | Social defeat stress causes depression-like behavior with metabolite changes in the prefrontal cortex of rats |
| Q36632940 | Therapeutic Effects of Chinese Medicine Herb Pair, Huzhang and Guizhi, on Monosodium Urate Crystal-Induced Gouty Arthritis in Rats Revealed by Anti-Inflammatory Assessments and NMR-Based Metabonomics |
| Q35777077 | Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis |
| Q26769944 | Urinary Biomarkers of Brain Diseases |
| Q57155162 | Urinary biomarker panel for diagnosing patients with depression and anxiety disorders |
| Q93185341 | Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus |
| Q64262134 | Urinary metabolite signature in bipolar disorder patients during depressive episode |
| Q35645024 | Urinary metabonomics for diagnosis of depression in hepatitis B virus-infected patients |
| Q54957019 | β2-microglobulin induces depressive- and anxiety-like behaviors in rat. |
Search more.